https://www.cohenveteransbioscience.org/wp-content/themes/cvb-theme/assets/img/icon-news-card.png
BRAIN Commons collaboration with Michael J. Fox Foundation for Parkinson’s Research featured in Milken Institute Future of Health Summit 2019
A recent article by Todd Sherer, PhD, CEO of the Michael J. Fox Foundation for Parkinson's Research (MJFF), highlighted the collaboration between the BRAIN Commons and MJFF in their Parkinson's Progression Markers Initiative (PPMI) study.
In the article, Dr. Sherer notes that “Data commons such as BRAIN Commons from Cohen Veterans Bioscience are collecting data across not only studies but also brain diseases.”
Read the article: “A Prescription for Brain Disease Research”
Learn more about the Parkinson’s Progression Markers Initiative (PPMI)
Share this article:
More from CVB
https://www.cohenveteransbioscience.org/wp-content/uploads/2024/01/cv.webp
Genome-wide association analyses identify 95 risk loci and provide insights into the neurobiology of post-traumatic stress disorder
https://www.cohenveteransbioscience.org/wp-content/uploads/2022/11/bigstock-Dna-With-Unique-Connection-155670029.jpg
New meta-analysis builds upon PTSD genetics research, providing a foundation for the development of precision therapies
https://www.cohenveteransbioscience.org/wp-content/uploads/2022/06/CVB-Circuit-Newsletter-Header.png
The Circuit – April 2024
About Cohen Veterans Bioscience (CVB)
Cohen Veterans Bioscience is a non-profit 501(c)(3) biomedical research and technology organization dedicated to advancing brain health by fast-tracking precision diagnostics and tailored therapeutics.
